Skip to main content

New Bowie inpatient rehab center coming

A rendering of Encompass Health's new rehab in Bowie.
The new rehab in Bowie will be open by mid-2022. (Courtesy Encompass Health Corp.)

Birmingham, Alabama-based Encompass Health Corp. will build a new inpatient rehabilitation hospital in Bowie, its second in Maryland.

The 60-bed rehab center will be at the southeast corner of Melford Boulevard and Marconi Drive. It is expected to open in mid-2022. It will be on a six-acre site that is part of Melford Town Center in Bowie, and will serve all hospitals in Southern Maryland.

Encompass Health has another rehabilitation center on Maryland’s Eastern Shore in Salisbury. It’s among 137 inpatient rehab facilities the company operates nationwide.

The Bowie center will include care for patients recovering from stroke and other neurological disorders, brain injuries, spinal cord injuries, amputations and orthopedic conditions.

It will offer physical, occupational and speech therapies, as well as 24-hour nursing care.

All patient rooms will be private, and the hospital will include a therapy gym with advanced rehabilitation technology, on-site dining, a pharmacy and a therapy courtyard.

Encompass is the largest owner and operator of inpatient rehabilitation hospitals in the U.S.

Oil prices slip and Asian shares are mostly lower as investors sell chipmaker stocks

HONG KONG (AP) — Oil prices fell Wednesday and Asian shares were mostly trading lower as South Korea’s Kospi extended its losses after falling more than 16% over the past two days. Crude prices remain volatile after the U.S. said early Thursday it had conducted a “heavy wave” of strikes against Iran, responding to an attack on a U.S. base. U.S. futures edged higher after losses on Wall Street. In South Korea, recent drops in its benchmark Kospi, a big beneficiary of the global boom in artificial intelligence, have been seen by some analysts as a reflection of broader doubts about massive investments by technology giants in expanding capacity for AI.
Read Next Story